| |
 |
|
Class Information
Number: 514/327
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing > Chalcogen bonded directly to ring carbon of the piperidine ring
Description: Subject matter wherein chalcogen (i.e., oxygen, sulfur, selenium or tellurium) is bonded directly to a ring carbon of the piperidine ring.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6274584 |
Compounds with growth hormone releasing properties |
Aug. 14, 2001 |
| 6258827 |
Combinations for the treatment of parkinsonism containing selective NMDA antagonists |
Jul. 10, 2001 |
| 6242465 |
Compositions of optically pure (+) norcisapride |
Jun. 5, 2001 |
| 6235778 |
Aminoguanidines and alkoxyguanidines as protease inhibitors |
May. 22, 2001 |
| 6221878 |
Method for treatment of depression |
Apr. 24, 2001 |
| 6197791 |
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
Mar. 6, 2001 |
| 6194435 |
Lactams as selective factor Xa inhibitors |
Feb. 27, 2001 |
| 6191156 |
Compositions and methods for treating bladder dysfunction |
Feb. 20, 2001 |
| 6174879 |
Aminocyclohexylesters and uses thereof |
Jan. 16, 2001 |
| 6166039 |
Peripherally active anti-hyperalgesic opiates |
Dec. 26, 2000 |
| 6159989 |
Antagonists of gonadotropin releasing hormone |
Dec. 12, 2000 |
| 6156770 |
Compositions of optically pure (-) norcisapride and another therapeutic agent |
Dec. 5, 2000 |
| 6156769 |
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
Dec. 5, 2000 |
| 6150353 |
Therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders |
Nov. 21, 2000 |
| 6147093 |
Methods for treating gastroesophageal reflux disease |
Nov. 14, 2000 |
| 6136827 |
Cyclic amine modulations of chemokine receptor activity |
Oct. 24, 2000 |
| 6124323 |
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
Sep. 26, 2000 |
| 6114356 |
Method for treating gastrointestinal disorders using (+) norcisapride |
Sep. 5, 2000 |
| 6113937 |
Sustained release sufentanil compositions |
Sep. 5, 2000 |
| 6103735 |
Composition and method for treating allergic diseases |
Aug. 15, 2000 |
| 6087379 |
Cyclic amine derivatives |
Jul. 11, 2000 |
| 6069154 |
Methods for treating gastro-esophageal reflux disease using optically pure (+) cisapride |
May. 30, 2000 |
| 6066654 |
Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride |
May. 23, 2000 |
| 6066642 |
Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists |
May. 23, 2000 |
| 6063816 |
Hydroxamic acid compounds |
May. 16, 2000 |
| 6060475 |
Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof |
May. 9, 2000 |
| 6054457 |
Benzamide derivatives and their use as vasopressin antagonists |
Apr. 25, 2000 |
| 6048879 |
Methods for treating apnea, apnea disorders, bulimia, and other disorders using optically pure (+) norcisapride |
Apr. 11, 2000 |
| 6046213 |
Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
Apr. 4, 2000 |
| 6034079 |
Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
Mar. 7, 2000 |
| 6030988 |
Immediate release pH-independent solid dosage form of cisapride |
Feb. 29, 2000 |
| 6017933 |
Mannich bases of conjugated styryl ketones |
Jan. 25, 2000 |
| 6017932 |
Pharmaceutical compositions containing at least one NSAID having increased bioavailability |
Jan. 25, 2000 |
| 6011047 |
Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors |
Jan. 4, 2000 |
| 6008223 |
Therapeutic compounds |
Dec. 28, 1999 |
| 6008233 |
(1S,2S)-1-(4-hydroxyphenyl)-2-(4- hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
Dec. 28, 1999 |
| 6004993 |
N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses |
Dec. 21, 1999 |
| 5998399 |
Guanidine derivatives useful in therapy as inhibitors of nitric oxide synthetase |
Dec. 7, 1999 |
| 5998439 |
Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
Dec. 7, 1999 |
| 5998444 |
Piperidinyl compounds as NK1 or NK2 antagonists |
Dec. 7, 1999 |
| 5994372 |
Peripherally active anti-hyperalgesic opiates |
Nov. 30, 1999 |
| 5981539 |
Piperidine compounds as calcium channel blockers |
Nov. 9, 1999 |
| 5962477 |
Screening methods for cytokine inhibitors |
Oct. 5, 1999 |
| 5958952 |
Substituted phenylamindines, medicaments containing these compounds and process for producing them |
Sep. 28, 1999 |
| 5955478 |
Methods for treating gastrointestinal motility dysfunction using optically pure (+) cisapride |
Sep. 21, 1999 |
| 5955477 |
Methods for treating gastrointestinal motility dysfunction using optically pure (--) cisapride |
Sep. 21, 1999 |
| 5952354 |
Tris carbamic acid esters: inhibitors of cholesterol absorption |
Sep. 14, 1999 |
| 5952376 |
Trienyl compounds |
Sep. 14, 1999 |
| 5942523 |
Compounds which are selective antagonists of the human NK.sub.3 receptor and their use as medicinal products and diagnostic tools |
Aug. 24, 1999 |
| 5939411 |
Piperidine derivatives process for obtaining them and pharmaceutical compositions containing them |
Aug. 17, 1999 |
|
|
|
